Citigroup’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.89M | Buy |
217,335
+202,413
| +1,356% | +$5.52M | ﹤0.01% | 1719 |
|
|
2025
Q4 | $405K | Sell |
14,922
-7,472
| -33% | -$197K | ﹤0.01% | 3676 |
|
|
2025
Q3 | $579K | Sell |
22,394
-76,806
| -77% | -$1.78M | ﹤0.01% | 3501 |
|
|
2025
Q2 | $2.02M | Sell |
99,200
-31,488
| -24% | -$613K | ﹤0.01% | 2639 |
|
|
2025
Q1 | $2.37M | Buy |
130,688
+11,329
| +9% | +$253K | ﹤0.01% | 2552 |
|
|
2024
Q4 | $3.02M | Buy |
119,359
+68,629
| +135% | +$1.86M | ﹤0.01% | 2452 |
|
|
2024
Q3 | $1.72M | Buy |
50,730
+25,465
| +101% | +$970K | ﹤0.01% | 2792 |
|
|
2024
Q2 | $935K | Sell |
25,265
-155,715
| -86% | -$5.88M | ﹤0.01% | 2963 |
|
|
2024
Q1 | $7.6M | Buy |
180,980
+118,639
| +190% | +$4.87M | 0.01% | 1437 |
|
|
2023
Q4 | $2.47M | Sell |
62,341
-7,014
| -10% | -$206K | ﹤0.01% | 2060 |
|
|
2023
Q3 | $1.91M | Sell |
69,355
-1,479
| -2% | -$46.4K | ﹤0.01% | 2018 |
|
|
2023
Q2 | $2.4M | Sell |
70,834
-47,071
| -40% | -$1.59M | ﹤0.01% | 2034 |
|
|
2023
Q1 | $4.24M | Buy |
117,905
+54,408
| +86% | +$2.35M | 0.01% | 1583 |
|
|
2022
Q4 | $2.83M | Sell |
63,497
-125,915
| -66% | -$4.5M | ﹤0.01% | 1800 |
|
|
2022
Q3 | $5.32M | Buy |
189,412
+33,735
| +22% | +$1.03M | 0.01% | 1525 |
|
|
2022
Q2 | $4.2M | Buy |
155,677
+92,158
| +145% | +$2.68M | 0.01% | 1636 |
|
|
2022
Q1 | $2.16M | Sell |
63,519
-55,529
| -47% | -$1.78M | ﹤0.01% | 2300 |
|
|
2021
Q4 | $4.6M | Buy |
119,048
+9,739
| +9% | +$424K | ﹤0.01% | 1899 |
|
|
2021
Q3 | $5.9M | Sell |
109,309
-10,945
| -9% | -$514K | 0.01% | 1699 |
|
|
2021
Q2 | $4.02M | Sell |
120,254
-53,024
| -31% | -$1.46M | ﹤0.01% | 2096 |
|
|
2021
Q1 | $3.57M | Buy |
173,278
+137,687
| +387% | +$3.16M | ﹤0.01% | 2065 |
|
|
2020
Q4 | $624K | Buy |
+35,591
| New | +$641K | ﹤0.01% | 4007 |
|
|
2019
Q3 | – | Sell |
-200
| Closed | -$463 | – | 7701 |
|
|
2019
Q2 | $1K | Buy |
+200
| New | +$679 | ﹤0.01% | 7664 |
|
|
2019
Q1 | – | Sell |
-2,082
| Closed | -$11K | – | 7661 |
|
|
2018
Q4 | $6K | Sell |
2,082
-1,351
| -39% | -$6.63K | ﹤0.01% | 7296 |
|
|
2018
Q3 | $23K | Sell |
3,433
-12,638
| -79% | -$88.5K | ﹤0.01% | 7009 |
|
|
2018
Q2 | $121K | Buy |
16,071
+10,845
| +208% | +$145K | ﹤0.01% | 5537 |
|
|
2018
Q1 | $183K | Buy |
5,226
+3,266
| +167% | +$127K | ﹤0.01% | 5053 |
|
|
2017
Q4 | $83K | Buy |
1,960
+689
| +54% | +$29.5K | ﹤0.01% | 5805 |
|
|
2017
Q3 | $55K | Buy |
1,271
+70
| +6% | +$2.62K | ﹤0.01% | 5946 |
|
|
2017
Q2 | $44K | Sell |
1,201
-6,593
| -85% | -$292K | ﹤0.01% | 5874 |
|
|
2017
Q1 | $422K | Sell |
7,794
-20,538
| -72% | -$1.07M | ﹤0.01% | 4016 |
|
|
2016
Q4 | $1.5M | Buy |
28,332
+24,260
| +596% | +$1.38M | ﹤0.01% | 3261 |
|
|
2016
Q3 | $246K | Buy |
4,072
+948
| +30% | +$59K | ﹤0.01% | 4502 |
|
|
2016
Q2 | $206K | Sell |
3,124
-3,284
| -51% | -$208K | ﹤0.01% | 4470 |
|
|
2016
Q1 | $363K | Buy |
6,408
+4,585
| +252% | +$516K | ﹤0.01% | 4492 |
|
|
2015
Q4 | $428K | Sell |
1,823
-1,476
| -45% | -$322K | ﹤0.01% | 4015 |
|
|
2015
Q3 | $522K | Buy |
3,299
+1,840
| +126% | +$521K | ﹤0.01% | 3700 |
|
|
2015
Q2 | $552K | Sell |
1,459
-394
| -21% | -$156K | ﹤0.01% | 3614 |
|
|
2015
Q1 | $775K | Sell |
1,853
-856
| -32% | -$306K | ﹤0.01% | 3323 |
|
|
2014
Q4 | $741K | Buy |
2,709
+2,119
| +359% | +$527K | ﹤0.01% | 3450 |
|
|
2014
Q3 | $114K | Sell |
590
-78
| -12% | -$17K | ﹤0.01% | 4655 |
|
|
2014
Q2 | $163K | Sell |
668
-2,480
| -79% | -$560K | ﹤0.01% | 4302 |
|
|
2014
Q1 | $834K | Sell |
3,148
-1,780
| -36% | -$682K | ﹤0.01% | 3021 |
|
|
2013
Q4 | $1.79M | Buy |
4,928
+2,572
| +109% | +$991K | ﹤0.01% | 2672 |
|
|
2013
Q3 | $1.25M | Buy |
2,356
+2,163
| +1,121% | +$742K | ﹤0.01% | 2746 |
|
|
2013
Q2 | $46K | Buy |
+193
| New | +$38K | ﹤0.01% | 5418 |
|
Other funds holding CLDX
KCM
VCM
CC
EP